查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1691815

心臟衰竭 POC 和 LOC 设备市场 - 全球产业规模、份额、趋势、机会和预测，按测试类型、按技术、按最终用途、按地区和竞争细分，2020-2030F

Heart Failure POC And LOC Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By Technology, By End Use, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球心臟衰竭 POC 和 LOC 设备市场价值为 1.1024 亿美元，预计在预测期内将实现令人印象深刻的成长，到 2030 年的复合年增长率为 8.25%。全球心臟衰竭 POC 和 LOC 设备市场是指医疗保健产业内一个快速发展的领域，专注于开发和部署专为心臟衰竭患者设计的创新诊断和监测设备。这些设备旨在为心臟衰竭的检测、管理和治疗提供更有效率、更经济、更患者友善的解决方案。此外，某些发展也导致了全球心臟衰竭 LOC 和 POC 设备市场的成长。

市场概况
预测期 2026-2030
2024 年市场规模 1.1024亿美元
2030 年市场规模 1.7597 亿美元
2025-2030 年复合年增长率 8.25％
成长最快的领域 基因组检测
最大的市场 北美洲

晶片实验室 (LOC) 技术可实现快速、高通量分析，提高疾病诊断的易用性和可靠性。对基于 LOC 的检测的研发投入不断增加，特别是针对心臟衰竭等心血管疾病 (CVD) 的检测，正在推动市场成长。由于心血管疾病 (CVD) 是全球领先的死亡原因，对早期检测和有效管理的需求日益增加，从而推动了对诊断领域 LOC 技术的需求。向分散医疗保健和个人化医疗的转变正在加速采用即时诊断（POC）和 LOC 设备，提供更快、更容易获得的诊断解决方案。政府机构正在透过资助计划和监管批准积极支持 LOC 发展，鼓励进一步创新。

主要市场驱动因素

心臟衰竭盛行率上升

主要市场挑战

准确性和可靠性

主要市场趋势

人工智慧（AI）的融合

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第 5 章：全球心臟衰竭 POC 和 LOC 设备市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依测试类型（蛋白质体学测试、代谢组学测试、基因组学测试）
    • 依技术分类（微流体、基于阵列的系统、其他）
    • 按最终使用者（医院、门诊手术中心、復健中心、研究机构等）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第 6 章：北美心臟衰竭 POC 和 LOC 设备市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 加拿大
    • 墨西哥

第 7 章：欧洲心臟衰竭 POC 和 LOC 设备市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 英国
    • 义大利
    • 法国
    • 西班牙

第 8 章：亚太地区心臟衰竭 POC 和 LOC 设备市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 印度
    • 日本
    • 韩国
    • 澳洲

第 9 章：南美洲心臟衰竭 POC 和 LOC 设备市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲心臟衰竭 POC 和 LOC 设备市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 沙乌地阿拉伯
    • 阿联酋
    • 科威特

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 最新动态
  • 产品发布
  • 合併与收购

第 13 章：全球心臟衰竭 POC 和 LOC 设备市场：SWOT 分析

第 14 章：竞争格局

  • Abbott Laboratories Inc
  • Siemens Healthineers AG
  • Danaher Corp
  • Instrumentation Laboratory Co
  • F Hoffmann-La Roche AG
  • bioMerieux SA
  • Abaxis Inc
  • Quidel Corp
  • Jant Pharmacal Corp
  • Trinity Biotech plc

第 15 章：策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 18765

Global Heart Failure POC And LOC Devices Market was valued at USD 110.24 million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.25% through 2030. The Global Heart Failure POC and LOC Devices Market refers to a rapidly evolving sector within the healthcare industry that focuses on the development and deployment of innovative diagnostic and monitoring devices specifically designed for heart failure patients. These devices aim to provide more efficient, cost-effective, and patient-friendly solutions for the detection, management, and treatment of heart failure. Also, certain development also leads to the growth of global heart failure LOC and POC devices market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 110.24 Million
Market Size 2030USD 175.97 Million
CAGR 2025-20308.25%
Fastest Growing SegmentGenomic testing
Largest MarketNorth America

Lab-on-a-Chip (LOC) technology enables rapid, high-throughput analyses, improving ease of use and reliability in disease diagnosis. Growing R&D investments in LOC-based assays, particularly for cardiovascular diseases (CVD) such as heart failure, are driving market growth. With CVD being a leading cause of mortality worldwide, the increasing need for early detection and effective management is boosting demand for LOC technology in diagnostics. The shift towards decentralized healthcare and personalized medicine is accelerating the adoption of point-of-care (POC) and LOC devices, offering faster, more accessible diagnostic solutions. Government bodies are actively supporting LOC development through funding initiatives and regulatory approvals, encouraging further innovation.

Key Market Drivers

Rising Prevalence of Heart Failure

Heart failure is a pervasive and chronic cardiovascular condition, affecting millions of people worldwide. With an aging population, sedentary lifestyles, and an increasing prevalence of risk factors such as obesity and diabetes, the incidence of heart failure is on the rise. However, this health crisis has given rise to an opportunity for innovation in healthcare. The Global Heart Failure Point of Care (POC) and Lab on a Chip (LOC) Devices Market is experiencing remarkable growth due to the escalating prevalence of heart failure.

Diabetes is a global health crisis, placing a substantial burden on developing countries like India, which is often referred to as the diabetes capital of the world. According to the ICMR-INDIAB study, over 101 million people in India are living with diabetes. The disease is linked to high morbidity and mortality, with nearly 46% of diabetic patients developing cardiovascular disease (CVD) during their lifetime. CVD is a leading cause of death among Type 2 diabetes (T2D) patients, accounting for nearly 50% of diabetes-related fatalities. Approximately 30% of diabetic patients develop heart failure, and those with both T2D and heart failure face an eightfold higher risk of death compared to individuals without heart failure. These alarming statistics highlight the urgent need for early diagnosis, intervention, and innovative treatment strategies to reduce the impact of diabetes-related cardiovascular complications.

Key Market Challenges

Accuracy and Reliability

POC and LOC devices need to be highly accurate and reliable, as errors can lead to misdiagnoses or improper management of heart failure. Ensuring consistent accuracy remains a significant challenge, especially for smaller and portable devices.

Key Market Trends

Integration of Artificial Intelligence (AI)

Artificial intelligence is increasingly being incorporated into POC and LOC devices. AI can enhance diagnostic accuracy, personalize treatment plans, and provide predictive analytics to identify potential heart failure exacerbations before they occur.

Key Market Players

  • Abbott Laboratories Inc
  • Siemens Healthineers AG
  • Danaher Corp
  • Instrumentation Laboratory Co
  • F Hoffmann-La Roche AG
  • bioMerieux S.A.
  • Abaxis Inc
  • Quidel Corp
  • Jant Pharmacal Corp
  • Trinity Biotech plc

Report Scope:

In this report, the Global Heart Failure POC And LOC Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Heart Failure POC And LOC Devices Market, By Test Type:

  • Proteomic testing
  • Metabolomic testing
  • Genomic testing

Heart Failure POC And LOC Devices Market, By Technology:

  • Microfluidics
  • Array-based systems
  • Others

Heart Failure POC And LOC Devices Market, By End Use:

  • Clinics
  • Hospitals
  • Home
  • Assisted living healthcare facilities
  • Laboratory
  • Others

Heart Failure POC And LOC Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Heart Failure POC And LOC Devices Market.

Available Customizations:

Global Heart Failure POC And LOC Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Source
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Heart Failure POC And LOC Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test Type (Proteomic testing, Metabolomic testing, Genomic testing)
    • 5.2.2. By Technology (Microfluidics, Array-based systems, Others)
    • 5.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Rehabilitation Centers, Research Institutes, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Heart Failure POC And LOC Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Technology
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Heart Failure POC And LOC Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Heart Failure POC And LOC Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Heart Failure POC And LOC Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By End User

7. Europe Heart Failure POC And LOC Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Technology
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Heart Failure POC And LOC Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By End User
    • 7.3.2. United Kingdom Heart Failure POC And LOC Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By End User
    • 7.3.3. Italy Heart Failure POC And LOC Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By End User
    • 7.3.4. France Heart Failure POC And LOC Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Heart Failure POC And LOC Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By End User

8. Asia-Pacific Heart Failure POC And LOC Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Technology
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Heart Failure POC And LOC Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By End User
    • 8.3.2. India Heart Failure POC And LOC Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Heart Failure POC And LOC Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Heart Failure POC And LOC Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Heart Failure POC And LOC Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By End User

9. South America Heart Failure POC And LOC Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Technology
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Heart Failure POC And LOC Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Heart Failure POC And LOC Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Heart Failure POC And LOC Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By End User

10. Middle East and Africa Heart Failure POC And LOC Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Technology
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Heart Failure POC And LOC Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Heart Failure POC And LOC Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Heart Failure POC And LOC Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By End User
    • 10.3.4. Kuwait Heart Failure POC And LOC Devices Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type
        • 10.3.4.2.2. By Technology
        • 10.3.4.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Heart Failure POC And LOC Devices Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Abbott Laboratories Inc
    • 14.1.1. Business Overview
    • 14.1.2. Technology Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Key Personnel
    • 14.1.5. SWOT Analysis
  • 14.2. Siemens Healthineers AG
  • 14.3. Danaher Corp
  • 14.4. Instrumentation Laboratory Co
  • 14.5. F Hoffmann-La Roche AG
  • 14.6. bioMerieux S.A.
  • 14.7. Abaxis Inc
  • 14.8. Quidel Corp
  • 14.9. Jant Pharmacal Corp
  • 14.10.Trinity Biotech plc

15. Strategic Recommendations

16.About Us & Disclaimer